{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:32:02Z","timestamp":1786350722267,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jneuroim.2026.578959","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:58:06Z","timestamp":1779145086000},"page":"578959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical features and treatment response of anti-Neurofascin 155 antibody-positive neuropathy in neurological Institute of Thailand"],"prefix":"10.1016","volume":"418","author":[{"given":"Narupat","family":"Suanprasert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaichana","family":"Sinthuwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metha","family":"Apiwattanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchat","family":"Hanchaiphiboolkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jneuroim.2026.578959_bb0005","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1212\/WNL.0000000000004773","article-title":"Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies","volume":"90","author":"Burnor","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.578959_bb0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1468-1331.2009.02802.x","article-title":"A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"17","author":"Cocito","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2026.578959_bb0015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","article-title":"Advances in the diagnosis, pathogenesis and treatment of CIDP","volume":"7","author":"Dalakas","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2026.578959_bb0020","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/brain\/awx124","article-title":"Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy","volume":"140","author":"Delmont","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2026.578959_bb0025","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin\u00ad155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.578959_bb0030","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/mus.26010","article-title":"Neurofascin\u00ad155 IgG4 neuropathy: pathophysiological insights, spectrum of clinical severity and response to treatment","volume":"57","author":"Garg","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2026.578959_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117098","article-title":"Refractory CIDP: clinical characteristics, antibodies and response to alternative treatment","volume":"418","author":"Godil","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2026.578959_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.48.2.321","article-title":"Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy","volume":"48","author":"Gorson","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.578959_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.637336","article-title":"A systematic review and meta-analysis of auto- antibodies for diagnosis and prognosis in patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"15","author":"Guo","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.578959_bb0050","series-title":"Peripheral Neuropathy","first-page":"2221","article-title":"Chronic inflammatory demyelinating polyradiculopathy","author":"Hahn","year":"2005"},{"key":"10.1016\/j.jneuroim.2026.578959_bb0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.10.013","article-title":"IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: clinical significance and diagnostic utility of a conventional assay","volume":"301","author":"Kadoya","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2026.578959_bb0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.autrev.2011.05.012","article-title":"Autoimmune disorders affecting both the central and peripheral nervous system","volume":"11","author":"Kamm","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578959_bb0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jnnp.2005.065441","article-title":"Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases","volume":"77","author":"Kuwabara","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2026.578959_bb0075","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.66.5.677","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England","volume":"66","author":"Lunn","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.578959_bb0080","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3988\/jcn.2023.0055","article-title":"Clinical features of autoimmune nodopathy with anti-neurofascin-155 antibodies in South Koreans","volume":"20","author":"Lyou","year":"2024","journal-title":"J. Clin. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.578959_bb0085","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1212\/WNL.0000000000009189","article-title":"Antibodies against nodo-paranodal proteins are not present in genetic neuropathies","volume":"95","author":"Mart\u00edn-Aguilar","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.578959_bb0090","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001098","article-title":"Clinical and laboratory features in anti-NF155 autoimmune nodopathy","volume":"9","author":"Mart\u00edn-Aguilar","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.578959_bb0095","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2026.578959_bb0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/jns5.12038","article-title":"Impairment and disability in 20 CIDP patients according to disease activity status","volume":"18","author":"Panaite","year":"2013","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2026.578959_bb0105","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.578959_bb0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneurol.2017.84","article-title":"Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications","volume":"13","author":"Querol","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2026.578959_bb0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle Nerve"},{"issue":"24","key":"10.1016\/j.jneuroim.2026.578959_bb0120","doi-asserted-by":"crossref","first-page":"e2392","DOI":"10.1212\/WNL.0000000000012932","article-title":"Neurofascin-155. immunoglobulin subtypes: clinicopathologic associations and neurologic outcomes","volume":"97","author":"Shelly","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578959_bb0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nmd.2022.01.006","article-title":"Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy","volume":"32","author":"Tan","year":"2022","journal-title":"Neuromuscul. Disord."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.578959_bb0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/jnnp-2017-317192","article-title":"Autoimmune nodo-paranodopathies of peripheral nerve: the concept is gaining ground","volume":"89","author":"Uncini","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2026.578959_bb0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1474-4422(10)70041-7","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition","volume":"9","author":"Vallat","year":"2010","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578959_bb0140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nmd.2016.10.008","article-title":"Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-neurofascin 155 antibodies","volume":"27","author":"Vallat","year":"2017","journal-title":"Neuromuscul. Disord."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.578959_bb0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jns.12455","article-title":"European Academy Of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision","volume":"26","author":"Van den Bergh","year":"2021","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jneuroim.2026.578959_bb0150","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3389\/fimmu.2018.01029","article-title":"Autoantibodies against the node of ranvier in seropositive chronic inflammatory demyelinating polyneuropathy: diagnostic, pathogenic, and therapeutic relevance","volume":"9","author":"Vural","year":"2018","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.578959_bb0155","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/brainsci12111587","article-title":"Anti-NF155\/NF186 IgG4 antibody positive autoimmune nodopathy","volume":"12","author":"Wang","year":"2022","journal-title":"Brain Sci."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:17:13Z","timestamp":1786349833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826001074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0165572826001074"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578959","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and treatment response of anti-Neurofascin 155 antibody-positive neuropathy in neurological Institute of Thailand","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.578959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"578959"}}